During the last three months, the FDA approved several molecules and indications. In May, the following indications were approved: Fam-trastuzumab...
Ivosidenib
Several indications and molecules were approved in August by FDA including the following: 1- Lenvatinib plus pembrolizumab for first-line treatment...
